Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform

Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform

LAS VEGAS, NEVADA / ACCESS Newswire / May 27, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial…

LifeArc supports research to develop a quick, affordable blood test for the early detection of dementia

As part of a collaboration with UK Dementia Research Institute, we are supporting research to validate a new blood test to detect the earliest signs of neurogenerative conditions, potentially years before symptoms occur.  Protein aggregation and associated inflammation play a key role in all neurodegenerative diseases and are known to occur early in disease progression. Professor Sir David Klenerman and his team at the University of Cambridge ar…